Establishment of a model of renal impairment with mild renal insufficiency associated with atrial fibrillation in canines

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Liang, Zhuo ^a   Liu, Li Feng ^a   Chen, Xin Pei ^a   Shi, Xiang Min ^a   Guo, Hong Yang ^a   Lin, Kun ^a   Guo, Jian Ping ^a   Shan, Zhao Liang ^a   Wang, Yu Tang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CREATININE; GELATIN SPONGE; LACTATE DEHYDROGENASE; LACTIC ACID; NITROGEN; NORADRENALIN; POTASSIUM; RENIN; SODIUM; UREA; C REACTIVE PROTEIN; MALONALDEHYDE;

ADRENERGIC SYSTEM; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOG; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HISTOLOGY; INFLAMMATION; KIDNEY ARTERY EMBOLIZATION; KIDNEY FAILURE; KIDNEY FUNCTION; MILD RENAL IMPAIRMENT; NONHUMAN; NORADRENALIN BLOOD LEVEL; OXIDATIVE STRESS; P WAVE; PLASMA RENIN ACTIVITY; REFRACTORY PERIOD; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; WENCKEBACH PERIOD; ANIMAL; ATRIAL FIBRILLATION; BLOOD; COMPLICATION; DISEASE MODEL; HEART VENTRICLE PRESSURE; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; VASCULARIZATION;

ANIMALS; ATRIAL FIBRILLATION; BLOOD PRESSURE; C-REACTIVE PROTEIN; DISEASE MODELS, ANIMAL; DOGS; KIDNEY; MALONDIALDEHYDE; NOREPINEPHRINE; OXIDATIVE STRESS; RENAL INSUFFICIENCY; RENIN; VENTRICULAR PRESSURE;

EID: 84928815483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105974     Document Type: Article

References (32)

1. Chen LY, Shen WK (2007) Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 4: S1-6.
2. Zimmerman D, Sood MM, Rigatto C, Holden RM, Hiremath S, et al. (2012) Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 27: 3816-3822.
3. Soliman EZ, Prineas RJ, Go AS, Xie D, Lash JP, et al. (2010) Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 159: 1102-1107.
4. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, et al. (2010) Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up. Heart Rhythm 8: 335-341.
5. Guo Y, Wang H, Zhao X, Zhang Y, Zhang D, et al. (2013) Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation. Int J Cardiol 168: 1502-1508.
6. Brown SA. (2013) Renal pathophysiology: lessons learned from the canine remnant kidney model. J Vet Emerg Crit Care (San Antonio) 23: 115-121.
7. Linz D, Neuberger HR (2012) Chronic kidney disease and atrial fibrillation. Heart Rhythm 9: 2032-2033.
8. Toshifumi W, Mika M (2007) Effects of Benazepril Hydrochloride in Cats with Experimentally Induced or Spontaneously Occurring Chronic Renal Failure. J. Vet. Med. Sci 69: 1015-1023.
9. Fukunaga N, Takahashi N, Hagiwara S, Kume O, Fukui A, et al. (2012) Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm 9: 2023-2031.
10. Alonso A, Lopez FL, Matsushita K, Loehr LR, Agarwal SK, et al. (2011) Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 123: 2946-2953.
11. Wang Y, Bao X (2013) Effects of uric acid on endothelial dysfunction in early chronic kidney disease and its mechanisms. Eur J Med Res 18: 26-36.
12. Ye S, Zhong H, Yanamadala V, Campese VM (2002) Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15: 717-724. (Pubitemid 34804278)
13. Ewen S, Ukena C, Linz D, Schmieder RE, Bohm M, et al. (2013) The sympathetic nervous system in chronic kidney disease. Curr Hypertens Rep 15: 370-376.
14. Kestenbaum B, Rudser KD, Shlipak MG, Fried LF, Newman AB, et al. (2007) Kidney function, electrocardiographic findings, and cardiovascular events among older adults. Clin J Am Soc Nephrol 2: 501-508.
15. Sapoznikov D, Dranitzki Elhalel M, Rubinger D (2013) Heart rate response to blood pressure variations: sympathetic activation versus baroreflex response in patients with end-stage renal disease. PLoS One 8: e78338.
16. Chan CT (2008) Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant 23: 3061-3062.
17. Redpath CJ, Rankin AC, Kane KA, Workman AJ (2006) Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol 40: 717-724.
18. Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, et al. (2004) Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43: 244-253. (Pubitemid 38146322)
19. Schotten U, Verheule S, Kirchhof P, Goette A (2011) Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 91: 265-325.
20. Siragy HM, Carey RM (2010) Role of the intrarenal renin- angiotensinaldosterone system in chronic kidney disease. Am J Nephrol 31: 541-550.
21. Mayyas F, Alzoubi KH, Van Wagoner DR (2013) Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol 168: 5135-5142.
22. Savelieva I, Kakouros N, Kourliouros A, Camm AJ (2011) Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. Europace 13: 610-625.
23. Thomas H, Jeffrey E (2007) Atrial Fibrosis and the Mechanisms of Atrial Fibrillation. Heart Rhythm 4: S24-S27.
24. Schlaich MP, Socratous F, Hennebry S, Eikelis N, Lambert EA, et al. (2009) Sympathetic activation in chronic renal failure. J Am Soc Nephrol 20: 933-939.
25. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, et al. (2011) Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension 57: 846-851.
26. Park HW, Shen MJ, Lin SF, Fishbein MC, Chen LS, et al. (2011) Neural mechanisms of atrial fibrillation. Curr Opin Cardiol 27: 24-28.
27. Hou Y, Hu J, Po SS, Wang H, Zhang L, et al. (2013) Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing. PLoS One 8: e78218.
28. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, et al. (2012) Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension 61: 225-231.
29. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, et al. (2012) Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 60: 172-178.
30. Zhao Q, Yu S, Huang H, Tang Y, Xiao J, et al. (2013) Effects of renal sympathetic denervation on the development of atrial fibrillation substrates in dogs with pacing-induced heart failure. Int J Cardiol 168: 1672-1673.
31. Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, et al. (2013) Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension 62: 767-774.
32. Zhao Q, Yu S, Zou M, Dai Z, Wang X, et al. (2012) Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 35: 119-125.